Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies.
第一作者:
Yinqiang,Zhang
第一单位:
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.;Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, 430022, China.
作者:
主题词
人类(Humans);T淋巴细胞(T-Lymphocytes);免疫疗法, 过继(Immunotherapy, Adoptive);前体T细胞淋巴母细胞白血病淋巴瘤(Precursor T-Cell Lymphoblastic Leukemia-Lymphoma);移植物抗宿主病(Graft vs Host Disease);抗原, CD19(Antigens, CD19)
DOI
10.1038/s41408-023-00822-w
PMID
37095094
发布时间
2023-05-12
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文